Since the publication of a number of reports describing diagnoses of serous endometrial cancer in BRCA1 pathogenic variant carriers of Ashkenazi Jewish heritage [[1], [2], [3]], there has been interest in a potential association between the BRCA pathogenic variants and an increased risk of endometrial cancer. The gene discussed is BRCA1; the disease is endometrial cancer.